Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Explore effective ways to earn money with side jobs now. Choose options that fit your lifestyle and start today.
22,363 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
A growing wave of AI-mediated workplace chats is changing how employees and managers communicate, with potential ripp...
Alphabet and Meta delivered divergent Q4 results, underscoring different paths to durable profits. Cloud, AI, and cap...
MP Materials faced a notable price drop in June, but the reasons run deeper than a single policy move. This article b...
Rivian is expanding beyond its trucks and SUVs into self-driving tech and ridesharing partnerships. This guide breaks...
NVIDIA's results grabbed headlines, but the stock moved in the opposite direction, sparking a broader market reaction...
As markets wobble in 2026, a growing corps of investors is skipping credential checklists in favor of a two-question ...
Choosing between SPDR REIT ETF and Vanguard Global ex-U.S. Real Estate ETF? This practical guide explains how each fu...
PayPal has faced a long stretch of underperformance, leaving investors wondering if the stock is a true bargain or a ...
Unpack the essentials of fulgent genetics (flgt) earnings in plain language. This guide translates the earnings trans...
Lionsgate delivered stronger-than-expected results, and its stock jumped. This article breaks down the key factors be...
In 2026, investors face a choice between a manufacturing giant expanding its foundry business and a nimble RFID IoT s...